Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 20/20 | 0.90 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.76 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.76 |
| ▸ | BCL2L2 | Q92843 | 2/20 | 0.76 |
| ▸ | NSD2 | O96028 | 1/20 | 0.76 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.76 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.76 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.76 |
| ▸ | BID | P55957 | 1/20 | 0.76 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.76 |
| ▸ | ASPH | Q12797 | 1/20 | 0.76 |
| ▸ | BAD | Q92934 | 1/20 | 0.76 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.76 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.76 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31450908 | 1.00 | BCL2 (0.90) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL26648486 | 0.96 | BCL2 (0.89) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL31450997 | 0.96 | BCL2 (0.89) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL25333323 | 0.95 | BCL2 (0.86) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL30485139 | 0.95 | BCL2 (0.86) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL25333332 | 0.95 | BCL2 (0.86) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL1702331 | 0.95 | BCL2 (1.00) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL30314207 | 0.95 | BCL2 (1.00) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL31450956 | 0.94 | BCL2 (0.90) | BCL2 | |
| SCHEMBL26648270 | 0.94 | BCL2 (0.90) | BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023220425-A1 | BCL-XL/BCL-2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220425-A1 | BCL-XL/BCL-2 DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |